ADCT
insider transactionsADC Therapeutics SA — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-5.9M
0 buy · 5.9M sell
Net value · 90d
-$19.6M
$0 in · $19.6M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
6
0 buy · 5.9M sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·F
Director
$38.8K
12.6K sh · $3.08
Own -10%
-
Other·F
Director
$46.8K
15.2K sh · $3.08
Own -11%
-
Other·F
Director
$38.8K
12.6K sh · $3.08
Own -8%
-
Other·F
Director
$8.0K
2.6K sh · $3.08
Own -1%
-
Other·F
Director
$6.6K
2.2K sh · $3.08
Own -1%
-
Other·F
Director
$38.8K
12.6K sh · $3.08
Own -8%
-
Other·F
Director
$38.8K
12.6K sh · $3.08
Own -15%
-
Grant·A
Director
$0
45.0K sh
Own +56%
-
Grant·A
Director
$0
45.0K sh
Own +48%
-
Grant·A
Director
$0
45.0K sh
Own +42%
-
Grant·A
Director
$0
45.0K sh
Own +31%
-
Grant·A
Director
$0
45.0K sh
Own +20%
-
Grant·A
Director
$0
45.0K sh
Own +42%
-
Grant·A
Director
$0
45.0K sh
Own +112%
-
Sell·S
$8.3M
2.5M sh · $3.28
Own -20%
-
Sell·S
$8.6M
2.6M sh · $3.28
Own -17%
-
Sell·S
$617.4K
162.5K sh · $3.80
Own -1%
-
Sell·S
$643.0K
169.3K sh · $3.80
Own -1%
-
Sell·S
$706.9K
188.4K sh · $3.75
Own -1%
-
Sell·S
$736.3K
196.2K sh · $3.75
Own -1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | Robert Azelby | Other F | 12.6K | $38.8K |
| Jun 3, 2026 | Ron Squarer | Other F | 15.2K | $46.8K |
| Jun 3, 2026 | Victor Sandor | Other F | 12.6K | $38.8K |
| Jun 3, 2026 | Viviane Monges | Other F | 2.6K | $8.0K |
| Jun 3, 2026 | Peter Hug | Other F | 2.2K | $6.6K |
| Jun 3, 2026 | Jean-Pierre Bizzari | Other F | 12.6K | $38.8K |
| Jun 3, 2026 | Timothy Coughlin | Other F | 12.6K | $38.8K |
| Jun 1, 2026 | Robert Azelby | Grant A | 45.0K | $0 |
| Jun 1, 2026 | Ron Squarer | Grant A | 45.0K | $0 |
| Jun 1, 2026 | Victor Sandor | Grant A | 45.0K | $0 |
| Jun 1, 2026 | Viviane Monges | Grant A | 45.0K | $0 |
| Jun 1, 2026 | Peter Hug | Grant A | 45.0K | $0 |
| Jun 1, 2026 | Jean-Pierre Bizzari | Grant A | 45.0K | $0 |
| Jun 1, 2026 | Timothy Coughlin | Grant A | 45.0K | $0 |
| Apr 2, 2026 | Redmile Group, LLC / Jeremy Green / RedCo II Master Fund, L.P. | Sell S | 2.5M | $8.3M |
| Apr 2, 2026 | Redmile Group, LLC / Jeremy Green / RedCo II Master Fund, L.P. | Sell S | 2.6M | $8.6M |
| Apr 1, 2026 | Redmile Group, LLC / Jeremy Green / RedCo II Master Fund, L.P. | Sell S | 162.5K | $617.4K |
| Apr 1, 2026 | Redmile Group, LLC / Jeremy Green / RedCo II Master Fund, L.P. | Sell S | 169.3K | $643.0K |
| Mar 31, 2026 | Redmile Group, LLC / Jeremy Green / RedCo II Master Fund, L.P. | Sell S | 188.4K | $706.9K |
| Mar 31, 2026 | Redmile Group, LLC / Jeremy Green / RedCo II Master Fund, L.P. | Sell S | 196.2K | $736.3K |
About ADCT insider trading
This page tracks insider transactions for ADC Therapeutics SA (ADCT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.